Jianmin Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,792.722 million compared to CNY 1,027.323 million a year ago. Operating income was CNY 187.119 million compared to CNY 62.248 million a year ago. Net income was CNY 167.152 million compared to CNY 57.196 million a year ago. Basic earnings per share from continuing operations was CNY 1.1 compared to CNY 0.37 a year ago.